Summit X’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
Summit X's IBRX Position: Q3 2025 in Review
Summit X sold out of ImmunityBio (IBRX) in Q3 2025, closing a stake of 10,664 shares — an estimated $28.2K sold.
Summit X first reported a position in IBRX in Q2 2025 and held it in 1 quarter. The position peaked at $28.2K in Q2 2025. 264 funds tracked by Wall St. Rank hold IBRX as of Q3 2025.
- Summit X reported no remaining ImmunityBio position as of Q3 2025 after selling out during the quarter.
- Summit X sold 10,664 ImmunityBio shares in Q3 2025, an estimated $28.2K.
- Summit X first reported a position in ImmunityBio in Q2 2025 and held it in 1 quarter.
- Summit X's ImmunityBio position peaked at $28.2K in Q2 2025.
- 264 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2025.
Based on Summit X's 13F filing for Q3 2025.